255 Deletion of the transcription factor Irf5 in macrophages leads to expansion of the subcutaneous fat depot but restriction of the visceral fat during obesity, resulting in improved insulin sensitivity.
http://www.nature.com/nm/journal/v21/n6/abs/nm.3829.html
254 Diabetes reversal in mice is achieved by transplanting islets into a prevascularized space under the skin.
http://www.nature.com/nbt/journal/v33/n5/abs/nbt.3211.html
253 Prolonged daily light exposure increases body fat mass through attenuation of brown adipose tissue activity.
http://www.pnas.org/content/112/21/6748.abstract
252 Stimulation of soluble guanylyl cyclase protects against obesity by recruiting brown adipose tissue.
http://www.nature.com/ncomms/2015/150526/ncomms8235/full/ncomms8235.html
251 Apolipoprotein CIII links islet insulin resistance to β-cell failure in diabetes.
http://www.pnas.org/content/112/20/E2611.abstract
250 Hematopoietic Kit Deficiency, rather than Lack of Mast Cells, Protects Mice from Obesity and Insulin Resistance.
http://www.cell.com/cell-metabolism/abstract/S1550-4131(15)00168-0
249 Hepatic insulin signalling is dispensable for suppression of glucose output by insulin in vivo.
http://www.nature.com/ncomms/2015/150512/ncomms8078/full/ncomms8078.html
248 A high-throughput chemical screen reveals that harmine-mediated inhibition of DYRK1A increases human pancreatic beta cell replication.
http://www.nature.com/nm/journal/v21/n4/abs/nm.3820.html
247 Characterization of pancreatic NMDA receptors as possible drug targets for diabetes treatment.
http://www.nature.com/nm/journal/v21/n4/abs/nm.3822.html
246 Promoting Health and Longevity through Diet: From Model Organisms to Humans.
http://www.cell.com/cell/abstract/S0092-8674(15)00186-5
|
